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Summary The radiation response of 5 different lines of human melanoma xenografts was studied. Tumours
grown s.c. in the flanks of athymic mice were exposed to single doses of 5-25Gy and subsequently analysed
with respect to specific growth delay. The variation in radiation response among these melanoma lines was
almost as large as that reported for human tumour xenografts differing in histological type. The most
radioresistant melanomas showed longer volume-doubling times, lower growth fractions, higher cell loss
factors and lower vascular density than the most radiosensitive ones. The radiation response was not
correlated to the fraction of cells in S-phase or the DNA content of the tumour cells. Cell suspensions
prepared from the different melanomas, irradiated under aerobic conditions and assayed in soft agar, also
showed large variability in radiation response. Specific growth delay after 15Gy was found to be correlated to
the surviving fraction measured in vitro after 6Gy, but not clearly to the Do value. It is suggested that tumour
growth characteristics in vivo as well as radiation response in vitro may be of prognostic value for prediction
of radioresponsiveness of melanomas.
Clinical studies have shown that some histological
types of human tumours are more radioresistant
than others (Rubin et al., 1974). However, histology
is probably not a major determinant of
radioresponsiveness since different tumours of the
same histological type may require totally different
doses to be locally controlled (Thames et al., 1980;
Peters & Fletcher, 1983). Several tumour
parameters, e.g. the number of clonogenic cells, the
fraction of hypoxic cells, the efficiency of
reoxygenation, the intrinsic cellular radiosensitivity
and the capacity for repair of sublethal and
potentially lethal damage, may affect the radio-
responsiveness of tumours. Thus, in attempts to
improve the efficacy of radiotherapy, it would
appear relevant to try to identify the major cause of
radioresistance of any given tumour population.
The major cause of radioresistance is not
necessarily the same in different tumour
populations, not even for tumours of equal
radiocurability. In some tumour populations,
several biological factors may contribute about
equally to the radioresistance, and hence no major
cause of radioresistance exists (Fowler, 1974; Peters
et al., 1983).
Since human tumours can be grown successfully
in congenitally athymic mice and immune-
Correspondence: E.K. Rofstad
Received 3 July 1984: and in revised form 25 October
1984.
suppressed mice, human tumour xenografts may be
used to identify causes of radioresistance in
different tumour populations (Rofstad, 1982).
Studies of growth delay caused by single dose
irradiation have shown that the radiation response
varies considerably among xenografts of different
histological types, and there is some evidence that
the radiation response correlates with the clinical
responsiveness of tumours of corresponding
histology (Steel, 1984). However, so far no studies
on the variability in radiation response in vivo
among xenografts of the same histological type
have been reported.
Biological characteristics of human melanoma
xenografts are currently studied at our institute.
The studies have been concentrated on 5 different
lines of xenografts of similar histology, which
originated from tumours in 5 different patients.
These xenograft tumour lines show individuality
with respect to: characteristic growth patterns
(Rofstad et al., 1982); vascular structures (Solesvik
et al., 1982); and, X-ray survival curves following
irradiation in vitro (Rofstad & Brustad, 1981). In
the present communication, we report on the
radiation response in vivo of these xenograft
tumour lines, using tumour growth delay as the
main endpoint. There was a dual purpose with the
work: (1) to quantify the variability in radiation
response among xenografts of the same histological
type followed by comparison to that reported
previously for xenografts of different histology; (2)
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to search for possible relationships between
radiation response and certain biological
characteristics of the xenografts in an attempt to
identify major causes of radioresistance following
single dose irradiation.
Materials and methods
Mice and tumours
Female BALB/c/nu/nu/BOM mice were used. They
were kept under specific pathogen-free (SPF)
conditions.
Five different human melanomas (E.E., E.F.,
G.E., M.F., V.N.), which each were derived from
metastases of patients at The Norwegian Radium
Hospital, were studied in the present work. The
melanomas were transplanted directly into athymic
mice without previous adaptation to in vitro culture
conditions. Histologically all of the 5 parent
metastases were similar. Both cells and nuclei varied
greatly in size and shape.
The melanomas were grown serially in athymic
mice by implanting fragments, 2 x 2 x 2mm in
size, s.c. into the flanks of recipient mice. Passages
20-52 in athymic mice were used in the present
study. The melanomas were kinetically stable
during the period the experiments were carried out,
as ascertained by flow cytometric measurements of
DNA histograms and measurements of volumetric
growth rates (Rofstad et al., 1982). Light and
electron microscopic examinations showed that the
histological appearance of the xenografts was
similar to that of the metastases in the donor
patients.
Irradiation and assay in vivo
Non-anaesthetized, air-breathing mice were irradia-
ted locally at a dose rate of 5.1 Gymin- by using
a "Stabilipan" X-ray unit, operated at 220kV and
20mA, with 0.5mm Cu filtration. A 15 x 15mm
hole through a 2cm thick lead block served as
beam-defining aperture. During exposure the mice
were kept in specially made, thin-walled Perspex
tubes with a hole in the cranial end through which
they could breathe freely. A piston in the tail end
positioned the mice firmly in the tubes. A hole was
cut in each tube through which the tumours
protruded. The tumour volumes at the time of
irradiation were 200-500mm3. To ensure uniform
doses throughout the tumour volumes, tumours
were exposed to irradiations by two opposing
treatment fields through each of which 50% of the
total dose was delivered.
The tumour volumes before and after irradiation
were measured with calipers. Two perpendicular
diameters (length and width) were recorded and the
tumour volumes were calculated as V= 1/2ab2
where a and b are the longest and the shortest
diameter, respectively. Since the skin around the
tumours was thin, the measured tumour diameters
were not corrected for the skin thickness.
The time taken for the irradiated (T'2) and the
control tumours (T2) to double their volume as
measured immediately before irradiation was
recorded. Actual tumour growth delay was
calculated as T'2- T2 and specific growth delay as:
T12-T2
T2
Specific growth delay may be regarded as an
estimate of the number of volume-doubling times
the growth is delayed after a given dose. This
parameter allows comparisons to be made between
the radiation response of tumours having different
growth rates prior to irradiation (Hermens &
Barendsen, 1975; Nowak et al., 1978; Steel et al.,
1983).
Irradiation and assay in vitro
First, single cell suspensions were prepared from
the melanomas and subsequently these were
irradiated under aerobic conditions and the colony
forming ability of the cells was assayed in soft agar
(Courtenay & Mills, 1978) as reported previously
(Rofstad & Brustad, 1981).
Biological characteristics
Biological characteristics of the melanomas have
also been reported previously: Growth fraction and
cell loss factor were calculated from PLM-curves,
labelling index data and growth curves (Rofstad et
al., 1977, 1980, 1982; Rofstad, 1984). Fraction of
cells in S-phase and DNA-index were calculated
from DNA-histograms obtained by flow cytometry
(Lindmo & Steen, 1977; Rofstad et al., 1982).
Vascular parameters were determined by
stereological analysis of histological sections from
tumours whose vascular system was filled with a
contrast medium (Solesvik et al., 1982).
Results and discussion
Variability in radiation response
Growth curves for irradiated and unirradiated
tumours are presented in Figure 1. Statistical
analysis showed that the response to a given dose
was independent of the pretr'eatment tumour
volume, which ranged from 200 to 500mm3. Thus,
mean normalized tumour volume is plotted versusX-RAY RESPONSE OF MELANOMA XENOGRAFTS 203
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Figure 1 Mean relative tumour volume as a function of time after single dose irradiation for human melanoma xenografts. Each curve is based on 15-25 tumours. The vertical bars represent s.e.
time after irradiation in Figure 1. Tumour growth
delay increased with increasing dose in the range 5-
25Gy. For the M.F. and the E.F. melanomas,
growth delays for doses above 15 and 20Gy,
respectively, could not be measured with sufficient
accuracy due to shortened life span of mice bearing
these xenografts.
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In Figure 2, growth delay and specific growth delay are shown as a function of radiation dose.
Both parameters vary considerably among the
melanomas. In order to base comparisons of the
radioresponsiveness of different tumours on
differences in the parameter specific growth delay, it is strictly a prerequisite that the average doubling
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Figure 2 Growth delay (a) and specific growth delay (b) as a function of radiation dose for human
melanoma xenografts. Each point represents mean values based on 15-25 tumours. The vertical bars represent
s.e.
time of the surviving clonogenic cells equals that of
the clonogenic cells in the untreated tumour.
Although the cell proliferation kinetics in tumours
may change after irradiation (Hermens &
Barendsen, 1969; Rofstad et al., 1980), the volume-
doubling time of the melanoma xenografts during
regrowth did not vary significantly with radiation
dose (Figure 1). Specific growth delay, as defined in
the present study, appears therefore to be an
acceptable parameter for comparing the
radioresponsiveness of the melanomas. Con-
sequently, Figure 2b shows that the 5 melanomas
studied are highly heterogeneous in radici-
responsiveness. Specific growth delay after 15Gy
was 5 times larger for the most sensitive
melanoma than for the most resistant one.
Steel (1984) has studied growth delay following
single dose irradiation of 5 human tumour
xenografts of different histology; a testicular
teratoma, a pancreatic carcinoma, a small-cell
bronchial carcinoma, a bladder carcinoma and a
bronchial adenocarcinoma. The results are redrawn
in Figure 3 where specific growth delay is shown as
a function of radiation dose. Steel (1984) concluded
that his data give some support for the assumption
that the radiation response of xenografts correlates
with the clinical responsiveness of tumours of
corresponding histology. The small-cell bronchial
carcinoma and the testicular teratoma xenografts
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Figure 3 Specific growth delay as a function of
radiation dose for human tumour xenografts.
Testicular teratoma (1), pancreatic carcinoma (2),
small-cell bronchial carcinoma (3), bladder carcinoma
(4) and bronchial adenocarcinoma (5) (Steel, 1984).
The hatched area represents the range of specific
growth delays for 5 melanomas (from Figure 2b).
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were relatively radiosensitive and these tumour
types are known to be radiosensitive clinically. The
bronchial adenocarcinoma and the bladder
carcinoma xenografts on the other hand were found
to be radioresistant as these tumour types often are
clinically. The hatched area in Figure 3 shows the
range of specific growth delays for the melanoma
xenografts, derived from Figure 2b. The two most
radioresistant melanomas showed about the same
specific growth delays as the bladder carcinoma
and the bronchial adenocarcinoma, whereas the
specific growth delays for the two most
radiosensitive melanomas were similar to those for
the small-cell bronchial carcinoma. Figure 3 thus
indicates that the difference in radioresponsiveness
among tumours of the same histological type may
be almost as large as that among tumours of
different histology. This suggests that histology is
of little importance to predict the radiation
response of tumours. Further studies with various
histological types of xenografts, carried out under
comparable experimental conditions and involving
fractionated irradiation, seem highly warranted.
Specific growth delay vs growth parameters
In order to identify biological differences between
the melanomas which may explain the variability in
radioresponsiveness, correlations between radio-
responsiveness and tumour growth parameters were
analysed. Specific growth delay after 15Gy was
used as measure of radioresponsiveness since 15 Gy
was the highest dose common for the melanomas.
The volume-doubling time of the melanomas
under the present growth conditions varied within a
factor of about five as did the specific growth delay
after 15Gy. Figure 4 shows specific growth delay
after 15Gy as a function of volume-doubling time
(T2). The melanomas having short volume-doubling
times were more radiosensitive than those having
long volume-doubling times.
Previous studies have shown that the rapidly
growing melanomas have higher growth fractions
and lower cell loss factors than the slowly growing
ones (Rofstad et al., 1982). Figure 5 shows specific
growth delay after 15Gy as a function of growth
fraction and cell loss factor. The figure indicates
that specific growth delay tended to increase with
increasing growth fraction which was also
concluded by Hermens & Barendsen (1975), and to
decrease with increasing cell loss factor.
It has also been shown that the vascular volume
is larger for the rapidly than for the slowly growing
melanomas (Rofstad, 1984). Specific growth delay
after 15 Gy is shown as a function of vascular
density in Figure 6. Four different vascular
parameters were considered; capillary length, i.e.
length of vessels with diameters in the range 5-
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Figure 4 Specific growth delay after 15Gy as a
function of volume-doubling time for human
melanoma xenografts. The points and the bars
represent mean values + s.e.
15,m, total vessel length, total vessel surface and
total vessel volume - all per unit of histologically
intact tumour volume. Specific growth delay
increased with increasing vascular density,
whichever vascular parameter was considered.
Flow cytometric studies have shown that the
fraction of cells in S-phase and the DNA content of
the GI/GO cells vary considerably among the
melanomas (Rofstad et al., 1982). Since the
radiosensitivity of cells depends on their position in
the cell-cycle and since DNA is a primary target for
the action of ionizing radiation, it is interesting to
attempt to relate the radioresponsiveness of the
melanomas to the fraction of cells in S-phase and
the DNA-index. However, Figure 7 shows that
specific growth delay after 15Gy did not decrease
with increasing value of any of these two flow
cytometric parameters, as would be expected if
these parameters were of major importance for the
radioresponsiveness of the melanomas.
In conclusion, the most radioresistant melanomas
have the longest volume-doubling time, the lowest
growth fraction, the highest cell loss factor and the
lowest vascular density. There is also some evidence
from clinical studies that the radiation response of
tumours may be related to the pretreatment rate of
growth. Tubiana et al. (1975) reviewed data
reported in the literature and suggested that slowly
growing tumour types may respond more poorly to
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Figure 5 Specific growth delay after 15Gy as a function of growth fraction (a) and cell loss factor (b) for
human melanoma xenografts. The points and the bars represent mean values + s.e.
radiotherapy than rapidly growing ones. Also Breur
(1966), who studied the radiation response of lung
metastases, observed that tumour shrinkage
increased with increasing rate of pretreatment
growth. However, even if there is a correlation
between radioresponsiveness and tumour growth,
the present study indicates that it may be difficult
to predict radioresponsiveness from flow cytometric
measurements of DNA histograms.
Specific growth delay vs cellular radiosensitivity
Also the radiation response in vitro varied
significantly among the melanomas. Survival curves
for cells irradiated in suspension under aerobic
conditions are presented in Figure 8.
The question then arises whether the radiation
response in vivo is related to the cellular
radiosensitivity as measured in vitro. Specific
growth delay after 15 Gy is shown as a function of
surviving fraction in vitro after 6Gy in Figure 9a.
Six Gy was the highest dose common for the
melanomas under in vitro conditions, and the
surviving fractions after this dose were in the same
range as those measured in vitro following exposure
to 15 Gy in vivo (Rofstad, 1981; Flaten et al., 1981).
Figure 9a shows that specific growth delay in vivo
increased with decreasing surviving fraction in vitro.
If it is assumed that the differences in cell survival
measured at 6Gy among the melanomas are also
valid after exposure to 15 Gy in vivo, this
observation suggests that the radioresponsiveness in
vivo is correlated to the cellular radiosensitivity in
vitro. However, specific growth delay after 15Gy
did not appear to correlate to the Do value of the in
vitro survival curves (Figure 9b). The observation
that the specific growth delay after 15 Gy was
correlated to the surviving fraction after 6Gy, but
not clearly to the Do value, is due to the large
difference in shoulder-width among the in vitro
survival curves.
The present finding is in agreement with the
suggestions of Barendsen (1980, 1983) and Fertil &
Malaise (1981) that the cellular radiosensitivity is
among the main factors which are decisive for the
radioresponsiveness of tumours. Barendsen found
that in vitro survival curves might vary considerably
among cell lines established from different mouse
and rat tumours, and showed theoretically that this
variability would imply large differences in
radiocurability of the corresponding tumours. Fertil
& Malaise reviewed published survival curves for
cell lines established from human tumours and
showed that the survival level after 2Gy, but not
that after 8 Gy, was positively correlated to the
radioresponsiveness of tumours of corresponding
histological type.
Conclusion
In conclusion, the radiation response in vivo
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Figure 6 Specific growth delay after 15Gy as a function of (a) capillary length, i.e. length of vessels with
diameters in the range 5-15,m; (b) total vessel length; (c) total vessel surface and (d) total vessel volume - all
per unit of histologically intact tumour volume. The points and the bars represent mean values + s.e.
10
8
6
4
(J2
LO
a)
o
Cu
-o
o 12
20
.2
a) 10
U,
8
6
4
2 +4
I I I I
n,,
i I. I I I
I I 12 r-
-
a208 E.K. ROSTAD & T. BRUSTAD
4 -V.N.
- t .G.E.
E.E. I
I + M.F.
E.F.
I I II I I 1-
b
V.N. 4
- G.E.
4 E.E.
E.F. IM.F.
I 1 I I
11 13 15 17 19 21 23 30 34 38 42 46
Fraction of cells in S-phase (%) DNA-index
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Figure 8 Survival curves for cells from human melanoma xenografts irradiated under aerobic conditions in
vitro. The vertical bars represent s.e.
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Figure 9 Specific growth delay after 15Gy as a function of surviving fraction in vitro after 6Gy (a) and Do value in vitro (b) for human melanoma xenografts. The points and the bars represent mean values + s.e.
varied considerably among melanoma xenografts
derived from different patients. If the present data
are representative for melanomas in man, they
suggest that certain tumour growth parameters as
well as given dose-survival factors in vitro may be
of value for prognostication of the radio-
responsiveness of individual melanomas.
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